College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, China.
Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, China.
Int J Biol Macromol. 2022 Nov 30;221:486-495. doi: 10.1016/j.ijbiomac.2022.09.021. Epub 2022 Sep 7.
Polymeric micelle is a promising vehicle to improve the bioavailability and clinical outcomes of paclitaxel (PTX) which has been proven effective in the treatment of a wide range of cancers. However, conventional PTX formulation with the amphiphilic PEG-b-PLA usually suffers from insufficient PTX loading, low stability of PTX-micelles, and rapid PTX release due to low compatibility between PTX and PLA, limiting its clinical application. In this study, a novel nanoparticle platform was developed to improve the stability of PTX-loaded nanoparticles (NPs) and the delivery efficacy of PTX by integrating the flash nanoprecipitation (FNP) technique and a combination of amphiphilic PEG-PLA and super hydrophobic zein. The incorporation of zein led to the formation of distinct hydrophobic interiors of NPs which enhanced the interaction between PTX and NPs, therefore improving the encapsulation efficiency of PTX and sustained drug release compared with PEG-PLA micelles without zein. In addition, FNP allowed facile fabrication of PTX-NPs with smaller sizes and higher stability. These PTX-NPs showed superior sustained release of PTX and good cancer cell-killing in vitro. Among them, PTX-5k-16k-1Z NPs exhibited excellent biosafety and anti-tumor efficacy in a xenograft tumor model in mice, suggesting great potential in the delivery of hydrophobic drugs for cancer therapy.
聚合物胶束是一种很有前途的载体,可以提高紫杉醇(PTX)的生物利用度和临床疗效,已被证明对多种癌症的治疗有效。然而,具有两亲性 PEG-b-PLA 的常规 PTX 制剂通常由于 PTX 和 PLA 之间的低相容性而存在 PTX 载药量不足、PTX-胶束稳定性低和 PTX 释放过快的问题,限制了其临床应用。在这项研究中,通过整合闪式纳米沉淀(FNP)技术和两亲性 PEG-PLA 与超疏水玉米醇溶蛋白的组合,开发了一种新型纳米颗粒平台,以提高载有 PTX 的纳米颗粒(NPs)的稳定性和 PTX 的递送效果。玉米醇溶蛋白的掺入导致 NPs 形成独特的疏水性内部,增强了 PTX 与 NPs 之间的相互作用,因此与不含玉米醇溶蛋白的 PEG-PLA 胶束相比,提高了 PTX 的包封效率和持续药物释放。此外,FNP 允许轻松制备具有更小尺寸和更高稳定性的 PTX-NPs。这些 PTX-NPs 在体外表现出优异的 PTX 持续释放和良好的癌细胞杀伤能力。其中,PTX-5k-16k-1Z NPs 在小鼠异种移植肿瘤模型中表现出优异的生物安全性和抗肿瘤疗效,表明其在用于癌症治疗的疏水性药物递送上具有巨大潜力。